The term "preformulation studies" refers to research conducted during the early phases of developing therapeutic candidates into various dosage forms. During the preformulation step, these candidates' physical and chemical properties are investigated in order to discover the important features that influence the selection of the most appropriate candidate. Preformulation studies have been demonstrated to play a significant part in the drug discovery and development process since they are frequently used when valuable information about lead identification and optimization is required. Preformulation studies have been reported to be accurate predictors of changes that may occur during the combination process of the active pharmaceutical ingredient (API) with an appropriate delivery method that is meant to deliver the active ingredient to the patient safely and effectively.
Title : Microemulsion based in situ gel of erythromycin for ocular ailments
Dasharath Muljibhai Patel, Graduate School of Pharmacy, India
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Thymoquinone-induced cellular and mitochondrial health in hepatocellular and cholangiocellular carcinoma
Consolato M Sergi, University of Ottawa, Canada
Title : Points to consider for the manufacturing of cell and gene therapies
Richard Denk, SKAN AG, Switzerland
Title : Pharmacological features of sparsentan, a novel dual endothelin and angiotensin receptor antagonist
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Development and validation of RP-HPLC method for the dissolution study of tofacitinib in pharmaceutical solid dosage form
Narapereddy Krishna Prasad, Reckitt Benckiser LLC, United States
Title : Does erector spinae plane block improve respiratory outcomes in adults with rib fractures?
Katie Aldred, University of Liverpool, United Kingdom
Title : Interdisciplinary perspective towards therapeutic potential in antenatal care
Anita, DMIHER, India
Title : Augmented anti-atopic dermatitis effect of crisaborole nanoemulgel in 2,4-Di-nitrochlorobenzene induced (DNCB) atopic dermatitis (AD) in Balb/c mice
Dipti Srivastava, Hygia institute of pharmaceutical education and research, India
Title : Formulation, characterization and evaluation: Micellar loaded complex of cuminum cyminum to treat causing disease of COVID 19 (Respiratory Infection)
Rudra Pratap Singh Rajput, Royal College of Pharmacy, India